Skip to content

Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension

Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01725763
Acronym
CMR-PH
Enrollment
150
Registered
2012-11-14
Start date
2012-12-31
Completion date
2030-12-31
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elevated Mean Pulmonary Arterial Pressure, Normal Mean Pulmonary Arterial Pressure, Pulmonary Hypertension

Brief summary

Pulmonary hypertension (PH) is a life-threatening cardiovascular disease characterized by pathological elevation of mean pulmonary arterial pressure (mPAP) \>/= 25 mmHg at rest. mPAP \< 20 mmHg is defined as normal, values in the range between 21-24 mmHg are described as borderline PH diagnosed by right heart catheterization. Based on the etiology, PH is assigned to 5 groups (WHO, Data Point, 2008), whereas classification of disease is an important prognostic and therapy-deciding criterion. Cardiac magnetic resonance tomography (CMR) provides a reliable technique to estimate elevated mean pulmonary arterial pressure from period of existence of a vortical motion of blood flow in the main pulmonary artery. Vortex can be visualized in 3-dimensional vector field, particle trace and streamline representations and can be analysed with respect to vortex related measures (geometry of center, vortex formation, vorticity, propagation dynamics …). Furthermore T1-mapping and non-contrast enhanced lung perfusion/ventilation scans represent promising techniques for PH characterization. Aim of this explorative study is to 1. analyse PH-associated blood flow characteristics in the heart and the surrounding great vessels with respect to the 5 groups of PH, and 2. investigate the hemodynamic state of borderline PH compared to normal mPAP and manifest PH by non-contrast CMR.

Interventions

OTHERCardiac MRI

Sponsors

Medical University of Graz
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with suspected or known PH scheduled for routine right-heart catheterization, * ability to give informed consent.

Exclusion criteria

* General MR

Design outcomes

Primary

MeasureTime frameDescription
blood flow patterns2 yearsfluid dynamical properties of blood flow patterns in the heart and surrounding great vessels associated with ethiology of PH

Secondary

MeasureTime frameDescription
myocardial magnetic relaxation times2 yearsleft and right ventricular myocardial T1 times associated with ethiology of PH
pulmonary ventilation and perfusion2 yearspulmonary ventilation and perfusion associated with ethiology of PH

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026